Insighta Limited
@insighta.com
Insighta aims to revolutionize multi-cancer early detection. Backed by world-class science, robust capital resources of US$100m from Prenetics (NASDAQ: PRE), and led by successful entrepreneur Danny Yeung, Insighta is poised to transform cancer screening. This endeavour not only presents an unprecedented opportunity to save lives but also bolster Hong Kong's standing as a global hub for life sciences innovation.
Insighta Limited's Company Logos
Insighta Limited's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#EA121F
Crimson
234, 18, 31
356, 86, 49
0, 92, 87, 8
#F4868D
Froly
244, 134, 141
356, 83, 74
0, 45, 42, 4
#86121F
Tamarillo
134, 18, 31
353, 76, 30
0, 87, 77, 47
About Insighta Limited
Insighta Science is a pioneering brand revolutionizing early cancer detection through cutting-edge technology and a commitment to excellence. With a focus on saving lives through early detection, Insighta's breakthrough FRAGMA Liquid Biopsy Platform utilizes proprietary cfDNA technology to detect a wide range of cancers without invasive procedures.
Driven by a team of world-class scientists and guided by proven management, Insighta's technology has shown remarkable accuracy with high AUC values. The FRAGMA technology achieves impressive results, such as 0.98 AUC for Liver Cancer and 1.0 AUC for Colorectal Cancer.
Led by visionary leaders like Danny Yeung and esteemed board members, Insighta is dedicated to shaping a healthier future where early cancer detection is the norm, potentially benefiting over a billion people annually. Join us in our mission to save lives and transform diagnostics with Insighta Science.
